Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Mar 3, 2010The Coalition to Prevent DVT Sends Awareness into Motion with an Educational Program Focusing on Preventative Care Through Movement
-
Feb 23, 2010New Data Published by Journal of American Academy of Dermatology Demonstrated Sustained Efficacy Up to 25 Months
-
Jan 20, 2010"AFib Support Team" Offers Insights on Comprehensive Approach to Management of Serious Heart Condition
-
Oct 16, 2009- Elitek is now approved to manage a potentially life-threatening complication associated with anti-cancer treatment in adults -
-
Oct 6, 2009Taking Control of Your Diabetes (TCOYD) Calls on Marketing Leaders and Creative Minds to "Start Taking Action Now for Diabetes"
-
Oct 1, 2009Women may delay treatment or seek injectable procedures
-
Sep 16, 2009"AF Stat(TM) Call to Action for Atrial Fibrillation" Report Cites Limited Understanding, Disconnected Dialogue and Uncoordinated Care as Key Barriers to Improved Outcomes
-
Aug 24, 2009Approval Includes Use in Patients Two Years and Older with Seasonal Nasal Allergies Which Affect Forty Percent of Children in the U.S.
-
Aug 17, 2009- Prophylaxis with Lovenox® (enoxaparin sodium injection) offered a cost reduction per discharge -
-
Jul 15, 2009Leading international experts conclude that these analyses present inconclusive and conflicting data
-
Jul 2, 2009Multaq(R) approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter - - U.S. commercial launch planned for the summer of 2009
-
Jun 6, 2009A1C and FBG Results for Patients 65 and Under Treated with Lantus and NPH were Similar
-
Jun 6, 2009Study Presented at 69th Annual ADA Scientific Sessions Examined Efficacy and Safety of Basal-Prandial Treatment with Lantus(R) and Apidra(R)
-
Apr 21, 2009Web Site Teams Up with AnnaLynne McCord and Dr. Jeanine Downie to Provide Skin Care Tips and Expert Advice to Look and Feel Your Best by Prom Night
-
Feb 26, 2009Apidra(R) SoloSTAR(R) is a Convenient Insulin Delivery Device to Help Patients with Diabetes Improve Glycemic Control
-
Feb 11, 2009Multaq(R) (dronedarone) significantly reduced the risk of cardiovascular hospitalization or death by 24 percent in patients with atrial fibrillation
-
Feb 5, 2009Team Type 1 Expands Its Roster, Fielding Five Teams to Spread Personal Messages of Successful Diabetes Management to People Living with Type 1 and Type 2 Diabetes
-
Nov 11, 2008New post-hoc analysis from Athena Study showed that Multaq® on top of standard therapy significantly decreased the total number of hospital days by 28% in patients with atrial fibrillation or flutter
-
Oct 23, 2008Sanofi-aventis will comply with the European Authorities request to temporarily suspend the marketing authorisation of Acomplia® in obese and overweight patients and will make every effort to actively support patients and Health Care Professionals.
-
Oct 16, 2008Champions Hope to Inspire People Living with Uncontrolled Blood Sugar Levels to Join the Circle and Pledge to Get Serious About Managing Their Diabetes
-
Sep 23, 2008Randomized, double-blind, placebo-controlled study conducted in the U.S. demonstrated both the efficacy and safety of Nasacort AQ® in children with nasal symptoms associated with perennial allergic rhinitis
-
Sep 16, 2008Actress Phylicia Rashad Travels to P.A.D. “Hot Spots” During P.A.D. Awareness Month to Urge Diagnosed Residents to Seek Treatment
-
Sep 15, 2008McGill and Nationally Known Allergist Encourage Nasal Allergy Sufferers to Challenge Their Course and Offer Helpful Tips for the Fall
-
Sep 3, 2008This analysis showed that Multaq® (dronedarone) decreased the risk of stroke by 34% in patient with atrial fibrillation or atrial flutter already adequately treated by antithrombotic therapy
-
Jul 22, 2008Two Regimens Including Lantus® and Apidra® Resulted in Significant Reductions in A1C in Patients with Type 2 Diabetes, Whatever the Algorithm Used
-
Jun 19, 2008Schmidt teams up with Minor League BaseballTM to raise awareness of Benign Prostatic Hyperplasia (BPH), a condition affecting more than 8 million men in the U.S.
-
Jun 10, 2008Ambien CR® 12.5 mg significantly improved sleep onset, sleep maintenance and total sleep time compared to placebo
-
Jun 7, 2008Results Presented at the ADA’s Annual Scientific Sessions
-
Jun 7, 2008New data presented at the ADA’s Annual Scientific Sessions demonstrated the value of beginning insulin promptly when glycemic targets are not achieved with diet, exercise and oral medications alone
-
May 28, 2008FDA Approval Based on Updated Results Showing a 20% Reduction in the Risk of Death at Six Years and a 22% Improvement of Disease Free Survival at Five Years, For Stage III Colon Cancer, Post Surgery
-
May 27, 2008First Phase III study performed solely in high risk, node-negative high risk population to show significant improvement in Disease Free Survival (DFS)
-
May 5, 2008100% of Insulin Doses Administered Were Delivered Within Pre-Determined Guidelines and Standard Dosing Limitations
-
May 1, 2008Web Site Provides Expert Advice and Answers to Acne-Related Questions
-
Apr 2, 2008Inspirational Team of Athletes – Team Type 1 – Spreads Messages of Hope to Others with Diabetes and Steers Toward Its Ultimate Goal of Tour de France Competition
-
Dec 10, 2007Patients treated with Lovenox® (enoxaparin sodium injection) were also less likely to be readmitted to hospital within 90 days
-
Jun 29, 2007
-
Mar 26, 2007
-
Feb 12, 2007